These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 18373841

  • 21. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
    Watts RE, Odedra A, Marquart L, Webb L, Abd-Rahman AN, Cascales L, Chalon S, Rebelo M, Pava Z, Collins KA, Pasay C, Chen N, Peatey CL, Möhrle JJ, McCarthy JS.
    PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
    [Abstract] [Full Text] [Related]

  • 22. Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.
    Karunajeewa HA, Kemiki A, Alpers MP, Lorry K, Batty KT, Ilett KF, Davis TM.
    Pediatr Infect Dis J; 2003 Mar; 22(3):251-6. PubMed ID: 12634587
    [Abstract] [Full Text] [Related]

  • 23. Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
    Saito M, Mansoor R, Kennon K, Anvikar AR, Ashley EA, Chandramohan D, Cohee LM, D'Alessandro U, Genton B, Gilder ME, Juma E, Kalilani-Phiri L, Kuepfer I, Laufer MK, Lwin KM, Meshnick SR, Mosha D, Muehlenbachs A, Mwapasa V, Mwebaza N, Nambozi M, Ndiaye JA, Nosten F, Nyunt M, Ogutu B, Parikh S, Paw MK, Phyo AP, Pimanpanarak M, Piola P, Rijken MJ, Sriprawat K, Tagbor HK, Tarning J, Tinto H, Valéa I, Valecha N, White NJ, Wiladphaingern J, Stepniewska K, McGready R, Guérin PJ.
    BMC Med; 2020 Jun 02; 18(1):138. PubMed ID: 32482173
    [Abstract] [Full Text] [Related]

  • 24. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M, Bonkian LN, Yerbanga I, Kazienga A, Valéa I, Sorgho H, Ouédraogo JB, Mens PF, Schallig HDFH, Ravinetto R, d'Alessandro U, Tinto H.
    Malar J; 2020 Jan 06; 19(1):8. PubMed ID: 31906948
    [Abstract] [Full Text] [Related]

  • 25. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I, Beavogui AH, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, Camara D, Somé AF, Coulibaly AS, Traore OB, Dara N, Kabore MJ, Thera I, Compaore YD, Sylla MM, Nikiema F, Diallo MS, Dicko A, Gil JP, Borrmann S, Duparc S, Miller RM, Doumbo OK, Shin J, Bjorkman A, Ouedraogo JB, Sirima SB, Djimdé AA.
    Lancet Infect Dis; 2016 Feb 06; 16(2):189-98. PubMed ID: 26601738
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Artemether-lumefantrine for uncomplicated malaria: a systematic review.
    Omari AA, Gamble C, Garner P.
    Trop Med Int Health; 2004 Feb 06; 9(2):192-9. PubMed ID: 15040555
    [Abstract] [Full Text] [Related]

  • 31. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S, Guerra ÁP, Álvarez-Larrotta C, Bernal SD, Restrepo C, González C, Yasnot MF, Knudson-Ospina A.
    Trans R Soc Trop Med Hyg; 2017 Feb 01; 111(2):71-80. PubMed ID: 28460112
    [Abstract] [Full Text] [Related]

  • 32. Intravenous artesunate for severe malaria.
    Prescrire Int; 2008 Aug 01; 17(96):168-70. PubMed ID: 19492495
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of Quinine versus Artemether in the treatment of severe malaria.
    Rehman MU, Shrestha B, Zehri T, Thapa S.
    J Nepal Health Res Counc; 2013 Jan 01; 11(23):17-21. PubMed ID: 23787519
    [Abstract] [Full Text] [Related]

  • 34. Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence.
    Rehman K, Lötsch F, Kremsner PG, Ramharter M.
    Int J Infect Dis; 2014 Dec 01; 29():268-73. PubMed ID: 25448338
    [Abstract] [Full Text] [Related]

  • 35. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK, Cheu KW, N'Da D, Coghi P, Monti D.
    Infect Disord Drug Targets; 2013 Aug 01; 13(4):217-77. PubMed ID: 24304352
    [Abstract] [Full Text] [Related]

  • 36. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T.
    Bull World Health Organ; 1994 Aug 01; 72(2):233-8. PubMed ID: 8205643
    [Abstract] [Full Text] [Related]

  • 37. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D, Ndiaye JL, Sylla K, Ba MS, Tine RC, Faye B, Pene M, Ndiaye M, Seck A, Lo AC, Abiola A, Dieng Y, Gaye O.
    Med Sante Trop; 2016 Aug 01; 26(1):45-50. PubMed ID: 26644184
    [Abstract] [Full Text] [Related]

  • 38. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN.
    Lancet; 2007 Mar 03; 369(9563):757-765. PubMed ID: 17336652
    [Abstract] [Full Text] [Related]

  • 39. Artemisinin-based combination treatment of falciparum malaria.
    Nosten F, White NJ.
    Am J Trop Med Hyg; 2007 Dec 03; 77(6 Suppl):181-92. PubMed ID: 18165491
    [Abstract] [Full Text] [Related]

  • 40. Intravenous artesunate plus oral dihydroartemisinin-piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia.
    Sikora SA, Poespoprodjo JR, Kenangalem E, Lampah DA, Sugiarto P, Laksono IS, Ahmad RA, Murhandarwati EEH.
    Malar J; 2019 Dec 30; 18(1):448. PubMed ID: 31888655
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.